Search

Author/Creator Uematsu, Shinya

1. Addition of ramucirumab enhances docetaxel efficacy in patients who had received anti-PD-1/PD-L1 treatment. (June 2020)

Authors:
Tozuka, Takehiro; Kitazono, Satoru; Sakamoto, Hiroaki; Yoshida, Hiroshi; Amino, Yoshiaki; Uematsu, Shinya; Yoshizawa, Takahiro; Hasegawa, Tsukasa; Ariyasu, Ryo; Uchibori, Ken; Yanagitani, Noriko; Horai, Takeshi; Seike, Masahiro; Gemma, Akihiko; Nishio, Makoto
Journal:
Lung cancer
Issue:
Volume 144(2020)
Page Start:
71
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Association between continuous decrease of plasma VEGF-A levels and the efficacy of chemotherapy in combination with anti-programmed cell death 1 antibody in non-small cell lung cancer patients. (2020)

Authors:
Tozuka, Takehiro; Yanagitani, Noriko; Sakamoto, Hiroaki; Yoshida, Hiroshi; Amino, Yoshiaki; Uematsu, Shinya; Yoshizawa, Takahiro; Hasegawa, Tsukasa; Ariyasu, Ryo; Uchibori, Ken; Kitazono, Satoru; Seike, Masahiro; Gemma, Akihiko; Nishio, Makoto
Journal:
Cancer treatment and research communications
Issue:
Number 25(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Clinical efficacy of amrubicin in patients with small cell lung cancer relapse after first‐line treatment including immune checkpoint inhibitors: A retrospective multicenter study (TOPGAN 2021‐01). Issue 2 (21st November 2022)

Authors:
Uematsu, Shinya; Kitazono, Satoru; Tanaka, Hisashi; Saito, Ryota; Kawashima, Yosuke; Ohyanagi, Fumiyoshi; Tozuka, Takehiro; Ryosuke, Tsugitomi; Sakatani, Toshio; Horiike, Atsushi; Yoshizawa, Takahiro; Saiki, Masafumi; Tambo, Yuichi; Koyama, Junji; Kanazu, Masaki; Kudo, Keita; Tsuchiya‐Kawano, Yuk...
Journal:
Thoracic cancer
Issue:
Volume 14:Issue 2(2023)
Page Start:
168
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Histologic transformation of epidermal growth factor receptor–mutated lung cancer. (May 2022)

Authors:
Fujimoto, Daichi; Akamatsu, Hiroaki; Morimoto, Takeshi; Wakuda, Kazushige; Sato, Yuki; Kawa, Yoshitaka; Yokoyama, Toshihide; Tamiya, Motohiro; Hiraoka, Ryota; Shingu, Naoki; Ikeda, Hideki; Tamiya, Akihiro; Kanazu, Masaki; Miyauchi, Eisaku; Miura, Satoru; Yanai, Masaaki; Yomota, Makiko; Morinaga, ...
Journal:
European journal of cancer
Issue:
Volume 166(2022)
Page Start:
41
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Overcoming resistance by ALK compound mutation (I1171S + G1269A) after sequential treatment of multiple ALK inhibitors in non‐small cell lung cancer. Issue 3 (13th January 2020)

Authors:
Takahashi, Ken; Seto, Yosuke; Okada, Koutaroh; Uematsu, Shinya; Uchibori, Ken; Tsukahara, Mika; Oh‐hara, Tomoko; Fujita, Naoya; Yanagitani, Noriko; Nishio, Makoto; Okubo, Kenichi; Katayama, Ryohei
Journal:
Thoracic cancer
Issue:
Volume 11:Issue 3(2020)
Page Start:
581
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Poor efficacy of anti‐programmed cell death‐1/ligand 1 monotherapy for non‐small cell lung cancer patients with active brain metastases. Issue 9 (12th July 2020)

Authors:
Tozuka, Takehiro; Kitazono, Satoru; Sakamoto, Hiroaki; Yoshida, Hiroshi; Amino, Yoshiaki; Uematsu, Shinya; Yoshizawa, Takahiro; Hasegawa, Tsukasa; Ariyasu, Ryo; Uchibori, Ken; Yanagitani, Noriko; Horai, Takeshi; Seike, Masahiro; Gemma, Akihiko; Nishio, Makoto
Journal:
Thoracic cancer
Issue:
Volume 11:Issue 9(2020)
Page Start:
2465
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗